HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas S Lin Selected Research

tositumomab I-131 (Bexxar)

11/2020Phase 2 Study of Iodine-131 Tositumomab Plus Chemotherapy in Patients With Previously Untreated Mantle-Cell Lymphoma.
4/2016CHOP Chemotherapy Followed by Tositumomab and Iodine-131 Tositumomab for Previously Untreated Diffuse Large B-cell Lymphoma.
7/2003Autologous stem cell transplantation for non-Hodgkin's lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas S Lin Research Topics

Disease

33B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2013 - 08/2003
15Neoplasms (Cancer)
11/2018 - 07/2003
9Multiple Myeloma
10/2022 - 08/2007
7Lymphoma (Lymphomas)
01/2010 - 04/2002
6Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2020 - 04/2002
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2016 - 07/2003
6Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
03/2015 - 10/2008
5Tumor Lysis Syndrome
12/2009 - 08/2003
4Residual Neoplasm
01/2022 - 01/2007
4Leukemia
12/2013 - 05/2009
4Lymphadenopathy
01/2010 - 01/2009
3Disease Progression
11/2018 - 03/2010
3Infections
11/2018 - 07/2002
3Chromosome Aberrations (Chromosome Abnormalities)
03/2010 - 08/2008
3Cytokine Release Syndrome
12/2009 - 01/2009
3Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2009 - 07/2003
3Hematologic Neoplasms (Hematological Malignancy)
07/2008 - 03/2004
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
07/2010 - 01/2010
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2009 - 04/2007
2B-Cell Leukemia (Leukemia, B Cell)
05/2009 - 10/2007
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2006 - 02/2005
1Retinoblastoma (Glioblastoma, Retinal)
02/2014
1Cytopenia
02/2014
1Diarrhea
02/2014
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
06/2011
1Listeria Meningitis
10/2010
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
10/2010
1Virus Diseases (Viral Diseases)
10/2010
1Tonsillar Neoplasms
03/2010
1Graft vs Host Disease (Graft-Versus-Host Disease)
07/2008
1Invasive Fungal Infections
07/2008
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
04/2008
1T-Cell Lymphoma (Lymphoma, T Cell)
04/2008
1Hyperkalemia
11/2007

Drug/Important Bio-Agent (IBA)

14Rituximab (Mabthera)FDA Link
03/2015 - 07/2003
12alvocidib (flavopiridol)IBA
02/2014 - 04/2002
9Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2022 - 01/2007
8fludarabineIBA
12/2013 - 01/2009
7daratumumabIBA
10/2022 - 11/2018
7Monoclonal AntibodiesIBA
11/2018 - 07/2003
6Dexamethasone (Maxidex)FDA LinkGeneric
10/2022 - 12/2009
6Bortezomib (Velcade)FDA Link
10/2022 - 06/2011
6ofatumumabFDA Link
01/2017 - 01/2010
5Lenalidomide (CC 5013)FDA Link
01/2022 - 07/2009
5Alemtuzumab (Campath)FDA Link
12/2013 - 01/2005
4Pharmaceutical PreparationsIBA
11/2018 - 11/2007
4Cyclin-Dependent Kinases (cdk Proteins)IBA
11/2010 - 04/2002
3tositumomab I-131 (Bexxar)FDA Link
11/2020 - 07/2003
3IodineIBA
04/2016 - 07/2003
3Proteins (Proteins, Gene)FDA Link
07/2010 - 04/2002
3Pentostatin (Nipent)FDA LinkGeneric
05/2010 - 01/2007
3AntibodiesIBA
01/2010 - 08/2007
2Doxorubicin (Adriamycin)FDA LinkGeneric
04/2016 - 05/2012
2Vincristine (Oncovin)FDA LinkGeneric
04/2016 - 05/2012
2Prednisone (Sone)FDA LinkGeneric
04/2016 - 05/2012
2Cyclin D1IBA
02/2014 - 04/2002
2NF-kappa B (NF-kB)IBA
07/2010 - 08/2009
2lumiliximabIBA
01/2010 - 08/2007
2apolizumabIBA
12/2009 - 03/2004
2Chlorambucil (Leukeran)FDA Link
01/2009 - 12/2007
2Alkylating AgentsIBA
08/2008 - 12/2007
1CD20 AntigensIBA
11/2020
1Transaminases (Aminotransferases)IBA
02/2014
1tanespimycin (17AAG)IBA
07/2010
117- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA
07/2010
1Dacarbazine (DIC)FDA LinkGeneric
03/2010
1motexafin gadoliniumIBA
12/2009
1HLA Antigens (Human Leukocyte Antigens)IBA
12/2009
1Biological ProductsIBA
05/2009
1silvestrolIBA
05/2009
1GlucuronidesIBA
03/2009
1Clofarabine (Clolar)FDA Link
03/2009
1Purine NucleosidesIBA
03/2009
1purineIBA
08/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2008
1Infliximab (Remicade)FDA Link
07/2008
1SteroidsIBA
07/2008
1CalciumIBA
03/2008
1hydroxide ionIBA
12/2007
1flavoneIBA
11/2007
1Etoposide (VP 16)FDA LinkGeneric
08/2007
1Melphalan (Alkeran)FDA LinkGeneric
08/2007
1Busulfan (Busulfex)FDA Link
08/2007
1Death-Associated Protein KinasesIBA
06/2007
1Small Interfering RNA (siRNA)IBA
04/2007
1Complement System Proteins (Complement)IBA
04/2007
1romidepsin (FK228)FDA Link
02/2005
1Histone Deacetylases (Histone Deacetylase)IBA
02/2005
1Histone Deacetylase InhibitorsIBA
02/2005
1DepsipeptidesIBA
02/2005

Therapy/Procedure

20Therapeutics
01/2020 - 07/2003
8Stem Cell Transplantation
01/2020 - 07/2003
7Drug Therapy (Chemotherapy)
11/2020 - 07/2003
3Hematopoietic Stem Cell Transplantation
10/2008 - 07/2002
2Transplantation
11/2013 - 07/2008
2Renal Dialysis (Hemodialysis)
12/2009 - 11/2007
1Radiotherapy
11/2020
1Aftercare (After-Treatment)
01/2009
1Intravenous Infusions
11/2007
1Cell Transplantation
01/2006